Vance Terry

Avg. Two Year Performance

152% Avg. Purchase Return
59% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%(12%)(14%)3%152%
Purchase Success Rate1 of 10 of 10 of 11 of 11 of 1
Average Sale Return----------
Sale Success Rate----------

Enanta Pharmaceuticals Inc

Drugs » Biotechnology

Director:

Holdings: 5.8K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--